Treatment of hemangioma by transfection of antisense VEGF gene

Journal of Huazhong University of Science and Technology - Medical Science

Volumn 29, Issue 3, 2009, Pages 335-339

  Shan, Shengguo ^a   Shan, Guang ^a   Zhang, Duanlian ^b  

^a RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

^b WUHAN UNIVERSITY   (China)

Author keywords

Antisense, targeting vascular therapy; Hemangioma endothelial cells; VEGF

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; CYCLINE; MESSENGER RNA; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

ARTICLE; CAPILLARY HEMANGIOMA; ENDOTHELIUM CELL; GENE THERAPY; GENETIC TRANSFECTION; GENETICS; HUMAN; METABOLISM; PATHOLOGY; SKIN TUMOR; TUMOR CELL CULTURE; HEMANGIOMA, CAPILLARY; SKIN NEOPLASMS;

ENDOTHELIAL CELLS; GENE THERAPY; HEMANGIOMA, CAPILLARY; HUMANS; OLIGONUCLEOTIDES, ANTISENSE; PROLIFERATING CELL NUCLEAR ANTIGEN; RNA, MESSENGER; SKIN NEOPLASMS; TRANSFECTION; TUMOR CELLS, CULTURED; VASCULAR ENDOTHELIAL GROWTH FACTOR A; GENETIC THERAPY;

EID: 70349656339     PISSN: 16720733     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11596-009-0314-y     Document Type: Article

References (17)

1. A. Giatromanolaki V. Arvanitidou A. Hatzimichael, et al. 2005 The HIF-2alpha/VEGF pathway activation in cutaneous capillary haemangiomas Pathology 37 2 149 151
2. L. Zhang X. Lin W. Wang, et al. 2005 Circulating level of vascular endothelial growth factor in differentiating hemangioma from vascular malformation patients Plast Reconstr Surg 116 1 200 204
3. D.A. Marchuk 2001 Pathogenesis of hemangioma J Clin Invest 107 6 665 666
4. Y. Yu A.F. Flint J.B. Mulliken, et al. 2004 Endothelial progenitor cells in infantile hemangioma Blood 103 4 1373 1375
5. B.I. Rini 2005 VEGF-targeted therapy in metastatic renal cell carcinoma Oncologist 10 3 191 197
6. T. Matsui T. Ono M. Kito, et al. 1997 Extensive facial strawberry mark associated with cerebellar hypoplasia and vascular abnormalities J dermatol 24 2 113 116
7. Y. Yu A.F. Flint J.B. Mulliken, et al. 2004 Endothelial progenitor cells in infantile hemangioma Blood 103 4 1373 1375
8. T.V. Petrova T. Makinen K. Alitalo 1999 Signaling via vascular endothelial growth factor receptors Exp Cell Res 253 1 117 130
9. A. Matsuno T. Nagashima 2004 Specific gene suppression using antisense strategy for growth suppression of glioma Med Electron Microsc 37 3 158 161 (Pubitemid 40576032)
10. Z.P. Gu Y.J. Wang Y. Wu, et al. 2004 Synthesis of ribozyme against vascular endothelial growth factor165 and its biological activity in vitro World J Gastroenterol 10 10 1495 1498
11. J. Glade-Bender J.J. Kandel D.J. Yamashiro 2003 VEGF blocking therapy in the treatment of cancer Expert Opin Biol Ther 3 2 263 276
12. T.L. Underiner B. Ruggeri D.E. Gingrich 2004 Development of vascular endothelial growth factor receptor (VEGFR) kinase inhibitors as anti-angiogenic agents in cancer therapy Curr Med Chem 11 6 731 745
13. A.M. Dvorak D. Feng 2001 The vesiculo-vacuolar organelle (VVO). A new endothelial cell permeability organelle Histochem Cytochem 49 4 419 432
14. Qu-Hong J.A. Nagy D.R. Senger 1995 Ultrastructural localization of vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) to the abluminal plasma membrane and vesiculovacuolar organelles of tumor microvascular endothelium Histochem Cytochem 43 4 381 389
15. D. Trisciuoglio A. Iervolino G. Zupi, et al. 2005 Involvement of PI3K and MAPK signaling in bcl-2-induced vascular endothelial growth factor expression in melanoma cells Mol Biol Cell 6 9 4153 4162
16. P. Kumar A.I. Miller P.J. Polverini 2004 MAPK mediates gamma-irradiation-induced endothelial cell apoptosis, and vascular endothelial growth factor protects endothelial cells through the phosphoinositide 3-kinase-Akt-Bcl-2 pathway J Biol Chem 279 41 43352 43360
17. J.E. Nor J. Christensen D.J. Mooney, et al. 1999 Vascular endothelial growth factor (VEGF)-mediated angiogenesis is associated with enhanced endothelial cell survival and induction of Bcl-2 expression Am J Pathol 154 2 375 384